[HTML][HTML] Phenotype, susceptibility, autoimmunity, and immunotherapy between Kawasaki disease and coronavirus disease-19 associated multisystem inflammatory�…

MR Chen, HC Kuo, YJ Lee, H Chi, SC Li…�- Frontiers in�…, 2021 - frontiersin.org
Coronavirus disease-19 (COVID-19) in children is usually mild but some are susceptible to a
Kawasaki disease (KD)-like multisystem inflammatory syndrome in children (MIS-C) in the�…

[HTML][HTML] Pediatric inflammatory multisystem syndrome temporally related with SARS-CoV-2: immunological similarities with acute rheumatic fever and toxic shock�…

D Buonsenso, F Riitano, P Valentini�- Frontiers in Pediatrics, 2020 - frontiersin.org
Several studies demonstrated that COVID-19 in children is a relatively mild disease.
However, recently a more serious condition characterized by systemic inflammation with�…

[HTML][HTML] Immunopathogenesis of COVID-19 and early immunomodulators

KY Lee, JW Rhim, JH Kang�- Clinical and experimental pediatrics, 2020 - ncbi.nlm.nih.gov
The novel coronavirus disease 2019 (COVID-19) is spreading globally. Although its etiologic
agent is discovered as severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)�…

[HTML][HTML] Roles of oxidative injury and nitric oxide system derangements in Kawasaki disease pathogenesis: a systematic review

M Tsuge, K Uda, T Eitoku, N Matsumoto…�- International journal of�…, 2023 - mdpi.com
Kawasaki disease (KD) is an acute febrile vasculitis that occurs mostly in children younger
than five years. KD involves multiple intricately connected inflammatory reactions activated�…

[HTML][HTML] Perspective of immunopathogenesis and immunotherapies for Kawasaki disease

L Chang, HW Yang, TY Lin, KD Yang�- Frontiers in Pediatrics, 2021 - frontiersin.org
Kawasaki Disease (KD) is an acute inflammatory illness that mostly occurs in children below
5 years of age, with intractable fever, mucocutaneous lesions, lymphadenopathy, and�…

[HTML][HTML] Etiological and pathophysiological enigmas of severe coronavirus disease 2019, multisystem inflammatory syndrome in children, and Kawasaki disease

JW Rhim, JH Kang, KY Lee�- Clinical and Experimental Pediatrics, 2022 - ncbi.nlm.nih.gov
During the coronavirus disease 2019 (COVID-19) pandemic, a novel multisystem
inflammatory syndrome in children (MIS-C) has been reported worldwide since the first�…

[HTML][HTML] Our evolving understanding of Kawasaki disease pathogenesis: role of the gut microbiota

K Kaneko, S Akagawa, Y Akagawa, T Kimata…�- Frontiers in�…, 2020 - frontiersin.org
Kawasaki disease (KD) was first described by Dr. Tomisaku Kawasaki in 1967. The etiology
of KD has been studied comprehensively but remains largely unknown. The disease seems�…

[HTML][HTML] Common immunopathogenesis of central nervous system diseases: the protein-homeostasis-system hypothesis

KY Lee�- Cell & bioscience, 2022 - Springer
There are hundreds of central nervous system (CNS) diseases, but there are few diseases
for which the etiology or pathogenesis is understood as well as those of other organ-specific�…

[HTML][HTML] Findings on the relationship between intestinal microbiome and vasculitis

B Sun, X He, W Zhang�- Frontiers in Cellular and Infection�…, 2022 - frontiersin.org
The microbiome has been implicated in small-, medium-, large-, and variable-vessel
vasculitis. Dysbiosis can frequently be found in vasculitis patients with altered microbial�…

Adjuvant herbal therapy for targeting susceptibility genes to Kawasaki disease: an overview of epidemiology, pathogenesis, diagnosis and pharmacological treatment�…

B Tang, HH Lo, C Lei, WLW Hsiao, X Guo, J Bai…�- Phytomedicine, 2020 - Elsevier
Background Kawasaki disease (KD) is a self-limiting acute systemic vasculitis occur mainly
in infants and young children under 5 years old. Although the use of acetylsalicylic acid�…